Current approaches to the diagnosis and treatment of postmenopausal osteoporosis

Current approaches to the diagnosis and treatment of postmenopausal osteoporosis

Postmenopausal osteoporosis (OP) is a disease afflicting every three women above 50 years of age. The sociomedical significance of OP is determined by the development of fracture in minimal injuries resulting in disability and, occasionally, death. The review presents a new management strategy descr...

Full description

Bibliographic Details
Main Authors:	Irina Aleksandrovna Baranova, I A Baranova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2009-10-01
Series:	Терапевтический архив
Subjects:	postmenopausal osteoporosis fractures treatment strontium ranelate
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/30527

Similar Items

Strontium ranelate in the treatment of postmenopausal osteoporosis: results of administration in clinical practice
by: N V Toroptsova, et al.
Published: (2008-06-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

Comparison of the Effects of Strontium Ranelate and Raloxiphene on Bone Mineral Density in Postmenopausal Osteoporosis - Original Investigation
by: Figen Yılmaz, et al.
Published: (2009-04-01)

Strontium ranelate enriched Ruminococcus albus in the gut microbiome of Sprague–Dawley rats with postmenopausal osteoporosis
by: Xiao Xiao, et al.
Published: (2023-11-01)

THE PLACE OF STRONTIUM RANELATE IN THE TREATMENT OF PATIENTS WITH OSTEOPOROSIS (RESULTS OF THE MARC PROGRAM)
by: O. A. Nikitinskaya, et al.
Published: (2018-09-01)

STRONTIUM RANELATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: IMPACT OF VITAMIN D RECEPTOR AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 GENE POLYMORPHISMS ON BONE MINERAL DENSITY: A PILOT STUDY
by: M. Yu. Krylov, et al.
Published: (2017-07-01)

Treatment of primary osteoporosis in men
by: Giusti A, et al.
Published: (2014-12-01)

Influence of Various Strontium Formulations (Ranelate, Citrate, and Chloride) on Bone Mineral Density, Morphology, and Microarchitecture: A Comparative Study in an Ovariectomized Female Mouse Model of Osteoporosis
by: Agnieszka Tomczyk-Warunek, et al.
Published: (2024-04-01)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012-08-01)

Efficacy and safety of bivalos therapy for postmenopausal osteoporosis. results of russian multicenter trial
by: L Ia Rozhinskaia, et al.
Published: (2008-05-01)

The Short-Term Effects of Strontium Ranelate on Pain and Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Halil Koyuncu, et al.
Published: (2012-08-01)

STUDY OF ENDOTHELIAL PROTECTIVE AND OSTEOPROTECTIVE PROPERTIES OF ROSUVASTATIN, L-NORVALINE AND THEIR COMBINATIONS IN EXPERIMENTAL OSTEOPOROSIS
by: M. S. SOBOLEV, et al.
Published: (2017-12-01)

POSSIBILITIES AND PROSPECTS OF DOUBLE EFFECT DRUGS APPLICATION FOR SYSTEMIC OSTEOPOROSIS PHARMACOTHERAPY OF PATIENTS WITH BONE FRACTURES
by: A. Y. Kochish, et al.
Published: (2012-06-01)

A new contralateral atypical femoral fracture despite sequential therapy with teriparatide and strontium ranelate
by: Hanh H Nguyen, et al.
Published: (2017-06-01)

Osteoporosis treatment in postmenopausal women with pre-existing fracture
by: Ming-Huei Cheng, et al.
Published: (2012-06-01)

Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis
by: T.A. Rodrigues, et al.

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
by: T.A. Rodrigues, et al.
Published: (2018-06-01)

Chondroprotective effect of melatonin and strontium ranelate in animal model of osteoarthritis
by: Kássya Mycaela Paulino Silva, et al.
Published: (2021-04-01)

Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis
by: Thiago A. Rodrigues, et al.
Published: (2018-09-01)

Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01)

Vertebral Fracture in Postmenopausal Women with and without Osteoporosis
by: Merih Özgen, et al.
Published: (2017-08-01)

Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
by: Ahmet Aslan, et al.
Published: (2018-08-01)

Osteoporosis: from cost-effect characteristics to clinical efficacy and safety of strontium ranelate (bivaios)
by: Ia S Dydykina, et al.
Published: (2008-05-01)

Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

Advances in Osteoporotic Bone Tissue Engineering
by: Cosmin Iulian Codrea, et al.
Published: (2021-01-01)

Calcium Phosphate/Hyaluronic Acid Composite Hydrogels for Local Antiosteoporotic Drug Delivery
by: Alise Svarca, et al.
Published: (2022-07-01)

The Impact of Vertebral Fractures on Quality of Life in Postmenopausal Osteoporosis
by: Hakan Nur, et al.
Published: (2011-12-01)

The influence of individual genetic polymorphisms on postmenopausal osteoporosis treatment effectiveness
by: N. A. Reznichenko, et al.
Published: (2020-12-01)

Evaluation of Screening Status and Fracture Risks of Postmenopausal Women for Osteoporosis
by: Burhan BALABAN, et al.
Published: (2023-03-01)

Hormone replacement therapy in prevention and treatment of postmenopausal osteoporosis
by: Rajesh Hishikar, et al.
Published: (2014-01-01)

COMPREHENSIVE PREVENTION OF INSTABILITY IN HIP REPLACEMENT FOR HIP FRACTURES AND THEIR CONSEQUENCES IN POSTMENOPAUSAL OSTEOPOROSIS IN MULTIPAROUS WOMEN
by: A.A. RAZZOKOV, et al.
Published: (2020-03-01)

Guideline for diagnostic, prevention and treatment of postmenopausal osteoporosis
by: N.V. Grygorieva, et al.
Published: (2023-09-01)

Impacto de una alerta sanitaria sobre la utilización de ranelato de estroncio Impact of a health safety warning on strontium ranelate utilization
by: Eduardo Carracedo-Martínez, et al.
Published: (2010-04-01)

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
by: Virgínia Fernandes Moça Trevisani, et al.

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

THE INFLUENCE OF POSTMENOPAUSAL OSTEOPOROSIS AND SUBCLINICAL VERTEBRAL FRACTURES ON POSTMENOPAUSAL WOMEN’S QUALITY OF LIFE
by: L. A. Marchenkova, et al.
Published: (2016-02-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009-05-01)